Chang, C., Yeh, Y., Chan, Y., Liu, J., Chang, S., Lee, H., . . . See, L. (2017). Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in Taiwan. Cardiovasc Diabetol.
Stile di citazione ChicagoChang, Chia-Yu, et al. "Dipeptidyl Peptidase-4 Inhibitor Decreases the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Nationwide Cohort Study in Taiwan." Cardiovasc Diabetol 2017.
Citazione MLAChang, Chia-Yu, et al. "Dipeptidyl Peptidase-4 Inhibitor Decreases the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Nationwide Cohort Study in Taiwan." Cardiovasc Diabetol 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.